Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
Not yet recruiting · NCT06746753 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, Urogenital Diseases, kidney disorder, toxic shock syndrome, urinary system disorder | Not yet recruiting | Phase 4 | 2026-09-24 | NCT06746753 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| Wake Forest University Health Sciences | 284 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Wake Forest Baptist | Winston-Salem | United States | 52 |
| Massachusetts General Hospital-Harvard | Boston | United States | 1 |